Dr. Mohammad Asim is a Cancer Molecular Biologist who studies molecular mechanisms that drive prostate cancer progression in order to find novel and more effective treatments. His research has primarily focussed on understanding the role of the androgen receptor signalling in prostate cancer and how it is activated in cancer leading to drug resistance. Mohammad graduated with a PhD from Justus Liebig University for his work uncovering the role of signal transduction pathways and transcriptional corepressors in regulating androgen receptor signalling in prostate cancer.